Skip to main content
Daniel Yeh, MD, General Surgery, Miami, FL, Jackson Health System

DanielDanteYehMD

General Surgery Miami, FL

Trauma Surgery & Surgical Critical Care

Instructor in Surgery, Massachusetts General Hospital

Dr. Yeh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yeh's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Surgical Critical Care, 2009 - 2010
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Surgery, 2004 - 2009
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - Present
  • CO State Medical License
    CO State Medical License 2021 - 2025
  • FL State Medical License
    FL State Medical License 2016 - 2023
  • MA State Medical License
    MA State Medical License 2011 - 2018
  • American Board of Surgery Surgery
  • American Board of Surgery Surgical Critical Care

Awards, Honors, & Recognition

  • Fellow American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Underestimation of Unplanned Readmission After Colorectal Surgery: A National AnalysisDecember 2017

Press Mentions

  • USF Inventors Secure Record Number of Patents
    USF Inventors Secure Record Number of PatentsJune 15th, 2021
  • USF Inventors Post Record Patent Numbers, Ranking in the Nation’s Top 10 University Producers
    USF Inventors Post Record Patent Numbers, Ranking in the Nation’s Top 10 University ProducersJune 15th, 2021
  • Relief Therapeutics (RLF:SIX) Startet FDA-Studie Mit Aviptadil an Der University of Miami Zur Behandlung Von COVID-19-Induzierter Atemnot
    Relief Therapeutics (RLF:SIX) Startet FDA-Studie Mit Aviptadil an Der University of Miami Zur Behandlung Von COVID-19-Induzierter AtemnotApril 7th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations